Long non-coding RNA H19 in atherosclerosis: what role?

Mol Med. 2020 Jul 22;26(1):72. doi: 10.1186/s10020-020-00196-w.

Abstract

Atherosclerosis (AS) is widely accepted to be a multistep pathophysiological process associated with several other processes such as angiogenesis and inflammatory response. Long non-coding RNAs (lncRNAs) are non-protein coding RNAs (more than 200 nucleotides in length) and can regulate gene expression at the transcriptional and post-transcriptional levels. Recent studies suggest that lncRNA-H19 plays important roles in the regulation of angiogenesis, adipocyte differentiation, lipid metabolism, inflammatory response, cellular proliferation and apoptosis. In this review, we primarily discuss the roles of lncRNA-H19 in atherosclerosis-related pathophysiological processes and the potential mechanisms by which lncRNA-H19 regulates the development of atherosclerosis, to help provide a better understanding of the biological functions of lncRNA-H19 in atherosclerosis.

Keywords: Angiogenesis; Atherosclerosis; Inflammatory response; Lipid metabolism; LncRNA-H19.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipocytes / cytology
  • Adipocytes / metabolism
  • Animals
  • Apoptosis / genetics
  • Atherosclerosis / genetics*
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Cell Differentiation
  • Cell Proliferation
  • Disease Susceptibility
  • Gene Expression Regulation*
  • Gene Regulatory Networks
  • Humans
  • Lipid Metabolism
  • RNA Interference*
  • RNA, Long Noncoding / genetics*

Substances

  • H19 long non-coding RNA
  • RNA, Long Noncoding